h
Let’s Work Together
arrosa@select.com

Meet Arrosa, the perfect theme to elevate your online presentation with.

Search here!

Artículos de Apnea Tag

  • Autor:
  • Eduardo Anitua
  • Ronald M Sánchez-Ávila
  • Carlos A Robayo-Esper
  • Eva Villota-Deleu
  • Álvaro Fernández-Vega Sanz
  • Álvaro Fernández-Vega González
  • Borja de la Sen-Corcuera
  • Jesús Merayo-Lloves

The aim of this study was to evaluate the use of PRGF (plasma rich in growth factors) as an adjuvant to PPV (pars plana vitrectomy) in recurrent, persistent, or poor prognosis MH (macular hole). Patients with MH were treated with PPV plus adjuvant therapy (PRGF membrane (mPRGF) and injectable liquid PRGF (iPRGF)).

  • Autor:
  • Eduardo Anitua
  • Gorka Orive
  • Miriam Idoipe
  • Borja de la Sen-Corcuera
  • Ronald M Sánchez-Ávila
  • Carmen Sánchez-Pérez
  • María Satué
  • Antonio Sánchez-Pérez
  • Francisco Muruzabal
  • Luis Pablo

This prospective and comparative study aimed to compare the use of a conjunctival autograft (CAG), plasma rich in growth factors fibrin membrane (mPRGF) or amniotic membrane transplantation (AMT) in primary pterygium surgery.

Mucous membrane pemphigoid (MMP) is a heterogeneous group of chronic autoimmune subepithelial blistering diseases. Oral involvement is present in almost all patients, may represent the onset of the disease, and causes different degrees of pain, dysphagia, soreness, and bleeding. Treatment is based on systemic and/or oral corticoids, or other immunosuppressants. Occasionally, oral lesions can show a poor response to standard treatments.

Over the last three decades, there has been special interest in developing drugs that mimic the characteristics of natural tears for use it in the treatment of several ocular surface disorders. Interestingly, the composition of blood plasma is very similar to tears. Therefore, different blood-derived products like autologous serum (AS) and plasma rich in growth factors (PRGF) have been developed for the treatment of diverse ocular pathologies.

The application of the counter-torque technique has been proposed as a conservative and atraumatic alternative for the explantation of nonmobile dental implants. The objective of this report is to assess the performance of this technique in a large number of patients.

  • Autor:
  • Eduardo Anitua
  • Ricardo Tejero
  • Francisco Romero-Gavilán
  • Andreia Cerqueira
  • Iñaki García-Arnáez
  • Cristina Martinez-Ramos
  • Seda Ozturan
  • Raul Izquierdo
  • Mikel Azkargorta
  • Félix Elortza
  • Mariló Gurruchaga
  • Isabel Goñi
  • Julio Suay

Calcium ions are used in the development of biomaterials for the promotion of coagulation, bone regeneration, and implant osseointegration. Upon implantation, the time-dependent release of calcium ions from titanium implant surfaces modifies the physicochemical characteristics at the implant-tissue interface and thus, the biological responses

  • Autor:
  • Eduardo Anitua
  • Fernando Kirchner
  • Isidro Milani
  • Alex Martinez
  • Nicolas Kirchner-Bossi
  • Roberto Prado
  • Sabino Padilla

Plasma rich in growth factors (PRGF) is a leukocyte-free platelet-rich plasma (PRP) that is an effective biological approach to tissue repair and has been demonstrated to significantly improve multiple conditions, including low back pain and degenerative disc pathology

  • Autor:
  • Eduardo Anitua
  • Ronald M Sánchez-Ávila
  • Edmar Uribe-Badillo
  • Carlos Fernández-Vega González
  • Francisco Muruzabal
  • Borja de la Sen-Corcuera
  • Begoña Baamonde
  • Luis M Quirós
  • Jesús Merayo-Lloves

This study aimed to investigate the use of Plasma Rich in Growth Factors (PRGF) associated with tissue ReGeneraTing Agent (RGTA) drops for the treatment of noninfectious corneal ulcers